【结 构 式】 |
【分子编号】18084 【品名】[6-(benzyloxy)-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromen-2-yl]methanol 【CA登记号】 |
【 分 子 式 】C21H26O3 【 分 子 量 】326.43564 【元素组成】C 77.27% H 8.03% O 14.7% |
合成路线1
该中间体在本合成路线中的序号:(XXV)The esterification of (rac)-6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydro-2H-1-benzopyran-2-carboxylic acid (XXII) with diazomethane gives the methyl ester (XXIII), which is treated with Bn-Br and K2CO3 yielding the benzyl ether (XXIV). The reduction of the ester group of (XXIV) with LiAlH4 provides the carbinol (XXV), which is debenzylated with H2 over Pd/C to afford the racemic phenol (rac)-(XXVI). Optical resolution of (XXVI) by means of lipase PL-266 and vinyl acetate gives the chiral acetate (S)-(XXVII), which is rebenzylated with BnBr yielding the benzyl ether (XXVIII). The deacetylation of (XXVIII) with LiAlH4 in ethyl ether affords the carbinol (XXIX), which is oxidized with oxalyl chloride to the aldehyde (XXX). The condensation of (XXX) with the intermediate phosphonium salt (XXI) by means of n-BuLi in THF gives the olefin (XXXI), which is finally hydrogenated and debenzylated with H2 over Pd/C in ethyl acetate.
【1】 Nozawa, M.; et al.; Enantioselective synthesis of (2R,4'R,8'R)-alpha-tocopherol (vitamin E) based on enzymatic function. Chem Pharm Bull 2000, 48, 2, 272. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(XXI) | 40910 | triphenyl[(3R,7R)-3,7,11-trimethyldodecyl]phosphonium bromide | C33H46BrP | 详情 | 详情 | |
(XXII) | 21255 | Trolox; Trolox C; 6-hydroxy-2,5,7,8-tetramethyl-2-chromanecarboxylic acid | 53188-07-1 | C14H18O4 | 详情 | 详情 |
(XXIII) | 40911 | methyl 6-hydroxy-2,5,7,8-tetramethyl-2-chromanecarboxylate | C15H20O4 | 详情 | 详情 | |
(XXIV) | 40912 | methyl 6-(benzyloxy)-2,5,7,8-tetramethyl-2-chromanecarboxylate | C22H26O4 | 详情 | 详情 | |
(XXV) | 18084 | [6-(benzyloxy)-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromen-2-yl]methanol | C21H26O3 | 详情 | 详情 | |
(XXVI) | 21256 | 2-(hydroxymethyl)-2,5,7,8-tetramethyl-6-chromanol | C14H20O3 | 详情 | 详情 | |
(XXVII) | 40913 | [(2S)-6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromen-2-yl]methyl acetate | C16H22O4 | 详情 | 详情 | |
(XXVIII) | 40914 | [(2S)-6-(benzyloxy)-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromen-2-yl]methyl acetate | C23H28O4 | 详情 | 详情 | |
(XXIX) | 40915 | [(2S)-6-(benzyloxy)-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromen-2-yl]methanol | C21H26O3 | 详情 | 详情 | |
(XXX) | 40916 | (2S)-6-(benzyloxy)-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromene-2-carbaldehyde | C21H24O3 | 详情 | 详情 | |
(XXXI) | 40917 | (2S)-6-(benzyloxy)-2,5,7,8-tetramethyl-2-[(E,4R,8R)-4,8,12-trimethyl-1-tridecenyl]-3,4-dihydro-2H-chromene; benzyl (2S)-2,5,7,8-tetramethyl-2-[(E,4R,8R)-4,8,12-trimethyl-1-tridecenyl]-3,4-dihydro-2H-chromen-6-yl ether | C36H54O2 | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(I)Treatment of chromane (I) with metanesulfonyl chloride in pyridine at 0 C afforded mesylate (II), which was treated with 2-methylaminoethanol (III) to afford tertiary amine (IV). Reaction with SOCl2 gave chloride (V), and further reaction with p-hydroxybenzaldehyde (VI) provided (VII). Aldehyde (VII) was then condensed with 2,4-thiazolidinedione (VIII) in the presence of piperidine benzoate in toluene to furnish (IX). Finally, the benzyl protecting group was removed by treatment with acetic acid-hydrochloric acid at 60 C to give the title compound.
【1】 Reddy, K.A.; Lohray, B.B.; Bhushan, V.; Reddy, A.S.; Kishore, P.H.; Rao, VV.; Saibaba, V.; Bajji, A.C.; Rajesh, B.M.; Reddy, K.V.; Chakrabarti, R.; Rajagopalan, R.; Novel euglycemic and hypolipidemic agents: Part-2. Antioxidant moiety as structural motif. Bioorg Med Chem Lett 1998, 8, 9, 999-1002. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 18084 | [6-(benzyloxy)-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromen-2-yl]methanol | C21H26O3 | 详情 | 详情 | |
(II) | 18085 | [6-(benzyloxy)-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromen-2-yl]methyl methanesulfonate | C22H28O5S | 详情 | 详情 | |
(III) | 13324 | 2-Methylaminoethanol; 2-(Methylamino)-1-ethanol | 109-83-1 | C3H9NO | 详情 | 详情 |
(IV) | 18086 | 2-[[[6-(benzyloxy)-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromen-2-yl]methyl](methyl)amino]-1-ethanol | C24H33NO3 | 详情 | 详情 | |
(V) | 18087 | N-[[6-(benzyloxy)-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromen-2-yl]methyl]-N-(2-chloroethyl)-N-methylamine; N-[[6-(benzyloxy)-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromen-2-yl]methyl]-2-chloro-N-methyl-1-ethanamine | C24H32ClNO2 | 详情 | 详情 | |
(VI) | 13433 | 4-Hydroxybenzaldehyde; p-Hydroxybenzaldehyde | 123-08-0 | C7H6O2 | 详情 | 详情 |
(VII) | 18088 | 4-[2-[[[6-(benzyloxy)-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromen-2-yl]methyl](methyl)amino]ethoxy]benzaldehyde | C31H37NO4 | 详情 | 详情 | |
(VIII) | 10883 | 1,3-Thiazolane-2,4-dione; 2,4-Thiazolidinedione | 2295-31-0 | C3H3NO2S | 详情 | 详情 |
(IX) | 18089 | 5-[(Z)-(4-[2-[[[6-(benzyloxy)-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromen-2-yl]methyl](methyl)amino]ethoxy]phenyl)methylidene]-1,3-thiazolidine-2,4-dione | C34H38N2O5S | 详情 | 详情 |